EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS
Rc. Bargou et al., EXPRESSION OF THE BCL-2 GENE FAMILY IN NORMAL AND MALIGNANT BREAST-TISSUE - LOW BAX-ALPHA EXPRESSION IN TUMOR-CELLS CORRELATES WITH RESISTANCE TOWARDS APOPTOSIS, International journal of cancer, 60(6), 1995, pp. 854-859
We have studied the expression of the apoptosis-regulating genes bcl-2
, bcl-x, box and APO-1/fas (CD95) in human breast cancer. The expressi
on pattern of these genes in human breast-cancer tissues and breast-ca
ncer-derived cell lines was compared to that seen in normal breast epi
thelium and breast epithelial cell lines. No difference with regard to
bcl-2 and bcl-x(L) expression was observed between normal breast epit
helium and tumor tissue or breast cancer and non-malignant epithelial
cell lines. In contrast, bax-alpha, a splice variant of box, which pro
motes apoptosis, is expressed in high amounts in normal cell lines and
breast tissue, whereas only weak or no expression could be detected i
n cancer-cell lines and malignant tissue. In contrast to malignant cel
l lines, which express low levels of bax-alpha, non-malignant epitheli
al cell lines displaying high amounts of box-alpha were highly sensiti
ve to induction of programmed cell death by both serum starvation and
APO-1/fas (CD95) triggering. We therefore propose that dysregulation o
f apoptosis contributes to the pathogenesis of breast cancer, at least
in part, due to an imbalance between anti-apoptosis genes (such as bc
l-2/bcl-x) and apoptosis-promoting genes (box). (C) 1995 Wiley-Liss, I
nc.